Salinosporamide A: a highly cytotoxic... [Angew Chem Int Ed Engl. 2003] - PubMed

New polyhydroxy sterols: proteasome inhibitors from a marine sponge Acanthodendrilla sp. [J Nat Prod. 2003]
New polyhydroxy sterols: proteasome inhibitors from a marine sponge Acanthodendrilla sp.
Tsukamoto S, Tatsuno M, van Soest RW, Yokosawa H, Ohta T. J Nat Prod. 2003 Sep; 66(9):1181-5.
The core structure of TMC-95A is a promising lead for reversible proteasome inhibition. [Angew Chem Int Ed Engl. 2002]
The core structure of TMC-95A is a promising lead for reversible proteasome inhibition.
Kaiser M, Groll M, Renner C, Huber R, Moroder L. Angew Chem Int Ed Engl. 2002 Mar 1; 41(5):780-3.
Engineered biosynthesis of antiprotealide and other unnatural salinosporamide proteasome inhibitors. [J Am Chem Soc. 2008]
Engineered biosynthesis of antiprotealide and other unnatural salinosporamide proteasome inhibitors.
McGlinchey RP, Nett M, Eustáquio AS, Asolkar RN, Fenical W, Moore BS. J Am Chem Soc. 2008 Jun 25; 130(25):7822-3. Epub 2008 May 31.
Review The role of p27Kip1 in proteasome inhibitor induced apoptosis. [Cell Cycle. 2003]
Review The role of p27Kip1 in proteasome inhibitor induced apoptosis.
Drexler HC. Cell Cycle. 2003 Sep-Oct; 2(5):438-41.
Review The proteasome: a novel therapeutic target in haematopoietic malignancy. [Hematology. 2003]
Review The proteasome: a novel therapeutic target in haematopoietic malignancy.
Magill L, Walker B, Irvine AE. Hematology. 2003 Oct; 8(5):275-83.

Review Marine antitumor drugs: status, shortfalls and strategies. [Mar Drugs. 2010]
Review Marine antitumor drugs: status, shortfalls and strategies.
Bhatnagar I, Kim SK. Mar Drugs. 2010 Oct 15; 8(10):2702-20. Epub 2010 Oct 15.
Review Immense essence of excellence: marine microbial bioactive compounds. [Mar Drugs. 2010]
Review Immense essence of excellence: marine microbial bioactive compounds.
Bhatnagar I, Kim SK. Mar Drugs. 2010 Oct 15; 8(10):2673-701. Epub 2010 Oct 15.
Proteasome inhibition and its therapeutic potential in multiple myeloma. [Biologics. 2010]
Proteasome inhibition and its therapeutic potential in multiple myeloma.
Chari A, Mazumder A, Jagannath S. Biologics. 2010 Sep 28; 4:273-87. Epub 2010 Sep 28.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbia...
Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus salinospora.
Angew Chem Int Ed Engl. 2003 Jan 20 ;42(3):355-7.

PubMed
Fallopian canal meningocele: report of two cases.
Fallopian canal meningocele: report of two cases.
Otol Neurotol. 2009 Jun ;30(4):525-8.

PubMed
Let's celebrate human genetic diversity.
Let's celebrate human genetic diversity.
Nature. 2009 Oct 8 ;461(7265):726-8.

PubMed
New guidelines for the management of adult community-acquired pneumonia.
New guidelines for the management of adult community-acquired pneumonia.
Curr Opin Infect Dis. 2007 Apr ;20(2):170-6.

PubMed
Cell surface organization of stress-inducible proteins ULBP and MICA that stimul...
Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D.
J Exp Med. 2004 Apr 5 ;199(7):1005-10. Epub 2004 Mar 29 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed